Your Partner in Innovative Cancer Care

Together with you – the healthcare professional in practice or training – we’re finding the answers, insights, and treatment options that people with cancer deserve.

How to Refer a Patient

Memorial Sloan Kettering’s Patient Access Service is an easy way for doctors to refer a patient to a Memorial Sloan Kettering specialist. Find helpful phone numbers and other resources.

Fellowships

Our renowned fellowship programs prepare doctors for leadership roles in the care of people with cancer around the world.

Learn more

Clinical Trials

At any one time Memorial Sloan Kettering is running hundreds of clinical trials. Through these studies we can improve care for people with all types of cancer. Browse the MSK clinical trials that are currently enrolling new patients.

Prediction Tools

MSK’s researchers have developed prediction tools known as nomograms. These tests can help people with cancer and doctors make treatment decisions. The tools can be used to predict cancer outcomes. Nomograms also assess an individual’s risk based on the characteristics of their specific disease.

Clinical Updates & Insights

Get the latest updates from MSK doctors. Read about new treatments, clinical trials, and innovations in detecting and treating many cancers.

Although distraction osteogenesis is commonly employed in regular orthopedic surgery, its use in cancer patients is currently limited. But research shows that these durable reconstructions can provide superior opportunities for better long-term limb function and growth in this cohort.

Our recent research demonstrates that the thrombopoietin receptor agonist romiplostim effectively modifies chemotherapy-induced thrombocytopenia (CIT) in solid tumor patients, allowing a majority to resume chemotherapy

Research presented at the 2018 meeting of the American Society of Clinical Oncology showed that the relapse rate is low for melanoma patients treated with immunotherapy, but those who do relapse can respond a second time to immunotherapy. Dr. Chapman discusses the impact. (June 2018)